Laura Figulla
Founder at coramaze technologies GmbH
Profile
Laura Figulla is the founder of Coramaze Technologies GmbH, where she held the titles of Chief Executive Officer, Director, and MD since 2013.
She is also the founder of Mbiomics GmbH, where she currently holds the title of Chief Executive Officer since its founding in 2020.
Laura Figulla active positions
| Companies | Position | Start |
|---|---|---|
coramaze technologies GmbH
 coramaze technologies GmbH Medical SpecialtiesHealth Technology coramaze technologies GmbH operates as a medical device company which develops valve repair system. It offers mitramaze a novel concept for transcatheter mitral valve repair intended for treatment of inoperable patients suffering from severe functional mitral regurgitation. The company was founded by Laura Figulla and Till Neumann in 2013 and is headquartered in Munich, Germany. | Founder | 2012-12-31 |
Mbiomics GmbH
 Mbiomics GmbH Miscellaneous Commercial ServicesCommercial Services Mbiomics GmbH is a German company that specializes in microbiome analysis. The company is based in Munich, Germany. The company's patented precision technology allows for fast, quantitative, and accurate analysis of the microbiome, which creates a basis for various future clinical applications and accelerates microbiome-based therapeutics development. Mbiomics offers high-resolution measurements of the composition of the microbiome, combining DNA and RNA analysis with a highly standardized workflow and unique single/molecule detection to tackle the three key challenges in microbiome profiling. The company was founded in 2020 by Laura Figulla, Johannes B. Woehrstein, Heinrich Grabmayr, and Laura Figulla has been the CEO since 2020. | Chief Executive Officer | 2019-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
coramaze technologies GmbH
coramaze technologies GmbH Medical SpecialtiesHealth Technology coramaze technologies GmbH operates as a medical device company which develops valve repair system. It offers mitramaze a novel concept for transcatheter mitral valve repair intended for treatment of inoperable patients suffering from severe functional mitral regurgitation. The company was founded by Laura Figulla and Till Neumann in 2013 and is headquartered in Munich, Germany. | Health Technology |
Mbiomics GmbH
Mbiomics GmbH Miscellaneous Commercial ServicesCommercial Services Mbiomics GmbH is a German company that specializes in microbiome analysis. The company is based in Munich, Germany. The company's patented precision technology allows for fast, quantitative, and accurate analysis of the microbiome, which creates a basis for various future clinical applications and accelerates microbiome-based therapeutics development. Mbiomics offers high-resolution measurements of the composition of the microbiome, combining DNA and RNA analysis with a highly standardized workflow and unique single/molecule detection to tackle the three key challenges in microbiome profiling. The company was founded in 2020 by Laura Figulla, Johannes B. Woehrstein, Heinrich Grabmayr, and Laura Figulla has been the CEO since 2020. | Commercial Services |
- Stock Market
- Insiders
- Laura Figulla
